Journal of Clinical Lipidology

The October Issue of the JCL is here. First up in the #JCLSpotlight: "Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial." Read more: ow.ly/iXOi5103W2T

#JCLSpotlight: Sitosterol is highly effective for identifying ST, but its diagnostic performance declines in gray zone cases. A combined sterol-based model improves discrimination & supports a stepwise diagnostic strategy for children with suspected ST. 🔗ow.ly/x4Ey50ZZJq8

#JCLSpotlight: Infants of mothers living with ASCVD, but not those with FH, had higher risks of adverse birth outcomes and increased healthcare utilization in this retrospective US cohort study. 🔗ow.ly/L9aF50ZZJbz

#JCLSpotlight: NMR-derived total HDL particle concentration, rather than HDL-C, is independently associated with all-cause mortality in LTRs. HDL-P captures dimensions of HDL not reflected by HDL-C and could be an important mortality biomarker. 🔗ow.ly/6SR350ZZIXJ

We're thrilled to share that Daniel Gaudet, MD, PhD and Michael Miller, MD have been promoted from Associate Editors to Deputy Editors of the JCL. Their contributions have been invaluable & this is a well-deserved recognition of the impact they continue to make on the field.